Stockscreener 앱 받기
217.49
2.05%
4.37
시간 외 거래:
217.00
-0.49
-0.23%
전일 마감가:
$213.12
열려 있는:
$215.06
하루 거래량:
8.31M
Relative Volume:
1.19
시가총액:
$384.69B
수익:
$61.16B
순이익/손실:
$4.19B
주가수익비율:
92.10
EPS:
2.3614
순현금흐름:
$17.82B
1주 성능:
+5.99%
1개월 성능:
-6.29%
6개월 성능:
-6.07%
1년 성능:
+3.80%
1일 변동 폭
$214.85
$219.17
1주일 범위
$205.76
$219.17
52주 변동 폭
$164.39
$244.81
애브비 Stock (ABBV) Company Profile
명칭
Abbvie Inc
전화
(847) 932-7900
주소
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Compare ABBV vs LLY, JNJ, AZN, MRK
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
217.49 | 376.96B | 61.16B | 4.19B | 17.82B | 2.3614 |
LLY
Lilly Eli Co
|
919.77 | 792.08B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
244.44 | 584.06B | 94.19B | 26.80B | 19.70B | 11.05 |
AZN
Astrazeneca Plc
|
197.22 | 300.68B | 58.80B | 10.24B | 8.98B | 3.2788 |
MRK
Merck Co Inc
|
120.29 | 291.99B | 64.93B | 18.26B | 12.36B | 7.2751 |
애브비 Stock (ABBV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2026-02-20 | 개시 | Barclays | Overweight |
| 2026-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2026-01-07 | 재개 | UBS | Neutral |
| 2025-12-10 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-11-04 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2025-10-14 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-10-01 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-09-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2025-08-12 | 재개 | Piper Sandler | Overweight |
| 2025-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-12-05 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-11-04 | 업그레이드 | Argus | Hold → Buy |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-06-05 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-05-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-01-29 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-12-11 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-10-30 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-09-29 | 개시 | Raymond James | Outperform |
| 2023-07-25 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-04-05 | 다운그레이드 | Argus | Buy → Hold |
| 2023-03-01 | 개시 | Guggenheim | Buy |
| 2023-02-22 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | 업그레이드 | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-11-08 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-08-01 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | 개시 | SVB Leerink | Underperform |
| 2022-05-06 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2022-02-28 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-03 | 재확인 | BMO Capital Markets | Outperform |
| 2022-02-03 | 재확인 | Barclays | Equal Weight |
| 2022-02-03 | 재확인 | BofA Securities | Neutral |
| 2022-02-03 | 재확인 | Goldman | Neutral |
| 2022-01-13 | 개시 | Redburn | Buy |
| 2022-01-12 | 재확인 | BMO Capital Markets | Outperform |
| 2021-12-09 | 재개 | Wells Fargo | Overweight |
| 2021-11-23 | 업그레이드 | Societe Generale | Hold → Buy |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-23 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | 업그레이드 | Argus | Hold → Buy |
| 2020-05-18 | 재개 | BofA/Merrill | Neutral |
| 2020-05-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-05-11 | 재개 | Morgan Stanley | Overweight |
| 2020-04-20 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | 재확인 | Cowen | Outperform |
| 2019-09-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-08-20 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-04-29 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
모두보기
애브비 주식(ABBV)의 최신 뉴스
AbbVie (NYSE:ABBV) Shares Up 2%Time to Buy? - MarketBeat
Pfizer, Bain Must Litigate Cerevel Investors’ AbbVie Deal Suit - Bloomberg Law News
Bernstein Maintains AbbVie(ABBV.US) With Hold Rating, Maintains Target Price $225 - 富途牛牛
AbbVie Inc Stock (ABBV) Moved Up by 3.26% on Mar 31: Drivers Behind the Movement - TradingKey
/C O R R E C T I O N -- AbbVie/ - Investing News Network
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting® - AbbVie News Center
Will AbbVie's Oncology Drugs Aid Top Line in 2026? - tradingview.com
AbbVie to Host First-Quarter 2026 Earnings Conference Call - Moomoo
Range Financial Group LLC Has $1.08 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
J. Safra Sarasin Holding AG Sells 36,172 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Holdings Lifted by Mn Services Vermogensbeheer B.V. - MarketBeat
Financial Planning Hawaii Inc. Invests $2.90 Million in AbbVie Inc. $ABBV - MarketBeat
AbbVie (NYSE:ABBV) Stock Price Up 1.8%Should You Buy? - MarketBeat
AbbVie (ABBV) Gains As Market Dips: What You Should Know - Yahoo Finance
U.S. Naproxen Market Set for Dynamic Boom as Key Players AbbVie • Bayer • Amgen • Teva Pharmaceuticals - openPR.com
Gross profit of AbbVie, Inc. – BSESOF:4AB - TradingView
-0.83% for AbbVie stock as shares remain under key resistance levels - Traders Union
-0.83% for AbbVie stock as price remains below key moving averages - Traders Union
AbbVie Inc. $ABBV Stock Position Raised by TrueMark Investments LLC - MarketBeat
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks - The Motley Fool
AbbVie, Inc. Trade Ideas — BSESOF:4AB - tradingview.com
Taxes of AbbVie, Inc. – BSESOF:4AB - tradingview.com
Wedge Capital Management L L P NC Sells 6,019 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Stock Holdings Lifted by Waycross Partners LLC - MarketBeat
Is AbbVie Inc. (ABBV) one of the debt free halal stocks to buy? - MSN
Bell Bank Has $12.09 Million Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Dermatology Data Sparks Questions On Growth Potential And Valuation - Yahoo Finance Singapore
Wealthcare Advisory Partners LLC Grows Stake in AbbVie Inc. $ABBV - MarketBeat
Generate Investment Management Ltd Sells 49,224 Shares of AbbVie Inc. $ABBV - MarketBeat
TABR Capital Management LLC Takes Position in AbbVie Inc. $ABBV - MarketBeat
Exchange Traded Concepts LLC Increases Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. Shares Purchased by Capital Investment Advisors - National Today
AbbVie Inc. $ABBV Shares Bought by Capital Investment Advisors LLC - MarketBeat
AbbVie stock slips 0.83% as company highlights commitment to raising care standards at congress - Traders Union
Return on equity % of AbbVie, Inc. – BSESOF:4AB - TradingView
AbbVie: Strong 2026 Outlook, Expect Dividend Increases (NYSE:ABBV) - Seeking Alpha
AbbVie’s Global IBD Outcomes Study: What Treat-to-Target Data Could Mean for Investors - tipranks.com
AbbVie stock price forecast: bearish momentum persists as ABBV trades below major moving averages - Traders Union
AbbVie stock edges down after AAD2026 event highlights commitment to dermatology standards - Traders Union
Bispecific T-Cell Engagers Market Insights Report (2026-2030) Featuring Strategic Analysis of Pfizer, Johnson & Johnson, Roche, AbbVie, Sanofi and Other Key Players - Yahoo Finance
AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting - Yahoo Finance
World Investment Advisors Increases Position in AbbVie Inc. $ABBV - MarketBeat
Global X Japan Co. Ltd. Increases Stock Position in AbbVie Inc. $ABBV - MarketBeat
Synergy Asset Management LLC Sells 10,070 Shares of AbbVie Inc. $ABBV - MarketBeat
Here's How Many Shares of AbbVie (ABBV) Stock You'd Need for $10,000 in Yearly Dividends - The Globe and Mail
Dakota Wealth Management Raises Position in AbbVie Inc. $ABBV - MarketBeat
Integras Partners LLC's AbbVie Inc(ABBV) Holding History - gurufocus.com
AbbVie (NYSE:ABBV) Trading 1.9% HigherTime to Buy? - MarketBeat
AbbVie Inc. stock outperforms competitors on strong trading day - MarketWatch
Vanguard disaggregates holdings after internal realignment (ABBV) - Stock Titan
AbbVie stock price forecast: sustained weak momentum as ABBV recovers modestly to $207.15 - Traders Union
애브비 (ABBV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.72%
자본화:
|
볼륨(24시간):